(Q44659948)

5 December 2017

title

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer (English)

1 reference

5 December 2017

1 reference

Ahmed Elattar

1

1 reference

5 December 2017

Katharine G Warburton

2

1 reference

5 December 2017

Asima Mukhopadhyay

3

1 reference

5 December 2017

Rebecca M Freer

4

1 reference

5 December 2017

Fadhel Shaheen

5

1 reference

5 December 2017

Paul Cross

6

1 reference

5 December 2017

E Ruth Plummer

7

1 reference

5 December 2017

Craig N Robson

8

1 reference

5 December 2017

Richard J Edmondson

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

15 October 2011

1 reference

5 December 2017

1 reference

5 December 2017

volume

124

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

142-147

1 reference

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Epidemiology of cancer of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Androstenedione production by malignant epithelial ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

The human ovarian surface epithelium is an androgen responsive tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

A phase II study of flutamide in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Primary ovarian cancer chemotherapy: current standards of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Validation of tissue microarray technology in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Androgen receptor activity is inhibited in response to genotoxic agents in a p53-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.004

10.1016/J.YGYNO.2011.09.004

7 January 2021

Identifiers

DOI

1 reference

release_htyhxm2dy5cnjaw5sy5kcdid4q

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/htyhxm2dy5cnjaw5sy5kcdid4q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference